Pfizer – LCC – LHF – APQ Award Program
Improving the care and outcomes of Canadians living with metastatic NSCLC
In collaboration with Pfizer, Lung Health Foundation, and the Quebec Lung Association, Lung Cancer Canada offers a grant opportunity seeking proposals for quality improvement initiatives focused on improving the care of outcomes of Canadians living with metastatic non-small cell lung cancer (NSCLC), with a special focus on improving health equity in this setting.
Grant funding and general oversight of the funded projects will be provided directly from Pfizer on behalf of Pfizer and the collaborators.
Grants will be awarded in support of organizations/institutions working to improve the competence and performance of both the healthcare providers and healthcare systems in which they work with the goal of optimizing the care and outcomes of metastatic NSCLC patients with special focus on improving health equity in this setting.
Topics of highlighted interest include, but are not limited to: